Alpha Cognition (ACOG) Cash & Current Investments (2023 - 2025)
Alpha Cognition's (ACOG) quarterly Cash & Current Investments came in at $66.1 million in Q4 2025, up 36.12% year-on-year from $48.6 million in Q4 2024, and up 86.44% quarter-over-quarter from $35.5 million in Q3 2025.
Alpha Cognition (ACOG) Cash & Current Investments (2023 - 2025) Analysis & Trends
Alpha Cognition's Cash & Current Investments history runs 3 years deep, the most recent figure standing at $66.1 million for Q4 2025.
- On a quarterly basis, Cash & Current Investments rose 36.12% year-over-year to $66.1 million in Q4 2025; TTM through Dec 2025 was $66.1 million, a 36.12% increase from a year earlier, with the FY2025 full-year figure at $66.1 million, up 36.12% from the prior year.
- Cash & Current Investments grew to $66.1 million in Q4 2025 per ACOG's latest filing, from $35.5 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $66.1 million in Q4 2025 and bottomed at $163678.0 in Q1 2024.
- The 3-year median for Cash & Current Investments is $19.6 million (2024), against an average of $24.2 million.
- Biggest YoY gain for Cash & Current Investments was 27773.16% in 2025; the steepest drop was 36.12% in 2025.
- Year by year, Cash & Current Investments stood at $1.5 million in 2023, then surged by 3149.36% to $48.6 million in 2024, then soared by 36.12% to $66.1 million in 2025.
- Per Business Quant, the three latest ACOG Cash & Current Investments figures stand at $66.1 million (Q4 2025), $35.5 million (Q3 2025), and $39.5 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Alpha Cognition | 146.84 Mn | 80.73 Mn | 2.61 Mn | 66.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.11 Mn |
| Sep 30, 2025 | 35.46 Mn |
| Jun 30, 2025 | 39.46 Mn |
| Mar 31, 2025 | 45.62 Mn |
| Dec 31, 2024 | 48.56 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 163,678.00 |
| Dec 31, 2023 | 1.49 Mn |
| Sep 30, 2023 | 201,500.00 |